Endurant Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,627
| Closed | -$1.24M | – | 10 |
|
|
2023
Q4 | $1.24M | Sell |
2,627
-10,874
| -81% | -$5.03M | 7.1% | 4 |
|
|
2023
Q3 | $5.88M | Buy |
13,501
+7,865
| +140% | +$3.57M | 5.28% | 5 |
|
|
2023
Q2 | $2.5M | Sell |
5,636
-31,690
| -85% | -$14.6M | 2.19% | 15 |
|
|
2023
Q1 | $17.2M | Buy |
37,326
+11,249
| +43% | +$5.35M | 8.82% | 3 |
|
|
2022
Q4 | $13.4M | Buy |
26,077
+9,675
| +59% | +$4.91M | 5.43% | 6 |
|
|
2022
Q3 | $7.45M | Buy |
+16,402
| New | +$7.85M | 2.43% | 17 |
|
|
2021
Q3 | – | Sell |
-11,941
| Closed | -$4.56M | – | 55 |
|
|
2021
Q2 | $4.56M | Sell |
11,941
-19,857
| -62% | -$7.59M | 1.25% | 31 |
|
|
2021
Q1 | $11.4M | Buy |
31,798
+9,164
| +40% | +$2.95M | 2.98% | 12 |
|
|
2020
Q4 | $7.27M | Buy |
22,634
+4,725
| +26% | +$1.45M | 2.62% | 12 |
|
|
2020
Q3 | $4.81M | Sell |
17,909
-12,119
| -40% | -$3.26M | 1.42% | 22 |
|
|
2020
Q2 | $7.9M | Sell |
30,028
-13,323
| -31% | -$3.55M | 0.43% | 11 |
|
|
2020
Q1 | $9.84M | Sell |
43,351
-38,692
| -47% | -$10.5M | 4.46% | 7 |
|
|
2019
Q4 | $24.8M | Buy |
82,043
+56,386
| +220% | +$15.5M | 7.81% | 2 |
|
|
2019
Q3 | $6.16M | Buy |
+25,657
| New | +$7.03M | 2.21% | 17 |
|
|
2019
Q2 | – | Sell |
-9,084
| Closed | -$2.61M | – | 60 |
|
|
2019
Q1 | $2.61M | Buy |
+9,084
| New | +$2.63M | 1.03% | 33 |
|
|
2018
Q4 | – | Sell |
-17,008
| Closed | -$4.66M | – | 59 |
|
|
2018
Q3 | $4.66M | Sell |
17,008
-19,928
| -54% | -$5.17M | 2.07% | 20 |
|
|
2018
Q2 | $8.79M | Sell |
36,936
-7,169
| -16% | -$1.66M | 3.81% | 8 |
|
|
2018
Q1 | $9.69M | Buy |
44,105
+21,594
| +96% | +$5.07M | 3.62% | 9 |
|
|
2017
Q4 | $5.07M | Sell |
22,511
-10,300
| -31% | -$2.19M | 1.55% | 28 |
|
|
2017
Q3 | $6.23M | Sell |
32,811
-16,404
| -33% | -$3.12M | 1.89% | 18 |
|
|
2017
Q2 | $9.26M | Sell |
49,215
-6,883
| -12% | -$1.24M | 2.62% | 11 |
|
|
2017
Q1 | $9.28M | Buy |
56,098
+27,998
| +100% | +$4.45M | 2.98% | 8 |
|
|
2016
Q4 | $4.04M | Buy |
28,100
+20,271
| +259% | +$2.71M | 1.67% | 24 |
|
|
2016
Q3 | $981K | Sell |
7,829
-17,325
| -69% | -$2.24M | 0.36% | 54 |
|
|
2016
Q2 | $3.3M | Sell |
25,154
-18,470
| -42% | -$2.53M | 1.1% | 30 |
|
|
2016
Q1 | $6.06M | Buy |
43,624
+38,157
| +698% | +$5.1M | 1.96% | 24 |
|
|
2015
Q4 | $762K | Buy |
+5,467
| New | +$753K | 0.25% | 61 |
|
|
2015
Q3 | – | Sell |
-40,675
| Closed | -$6.68M | – | 84 |
|
|
2015
Q2 | $6.68M | Sell |
40,675
-2,800
| -6% | -$447K | 1.97% | 14 |
|
|
2015
Q1 | $6.71M | Sell |
43,475
-29,660
| -41% | -$4.22M | 2.22% | 11 |
|
|
2014
Q4 | $9.19M | Buy |
+73,135
| New | +$9.04M | 3.61% | 5 |
|
Other funds holding ELV
Endurant Capital Management's ELV Position: Q1 2024 in Review
Endurant Capital Management sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 2,627 shares — an estimated $1.24M sold.
Endurant Capital Management first reported a position in ELV in Q4 2014 and held it in 30 quarters. The position peaked at $24.8M in Q4 2019. 1,667 funds tracked by Wall St. Rank hold ELV as of Q1 2024.
- Endurant Capital Management reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
- Endurant Capital Management sold 2,627 Elevance Health shares in Q1 2024, an estimated $1.24M.
- Endurant Capital Management first reported a position in Elevance Health in Q4 2014 and held it in 30 quarters.
- Endurant Capital Management's Elevance Health position peaked at $24.8M in Q4 2019.
- 1,667 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.
Based on Endurant Capital Management's 13F filing for Q1 2024.